Skip to content

Clinical trials

Completed Phase 2 Parasomnias trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parasomnias Phase: Phase 2 Status: Completed Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20062
20092
20121
20161
20191
20202
20212
20222
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Johns Hopkins University3
Duke University2
Baylor College of Medicine1
Bod Australia1
Chang Gung Memorial Hospital1
Kaiser Permanente1
Lallemand Health Solutions1
Neurim Pharmaceuticals Ltd.1
Pippa Hawley1
Reconnect Labs1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parasomnias18
Sleep Initiation and Maintenance Disorders4
Post-Acute COVID-19 Syndrome3
Sleep Wake Disorders3
Alzheimer Disease2
Anxiety Disorders2
Disorders of Excessive Somnolence2
Opioid-Related Disorders2
Pain2
Sleep Apnea Syndromes2

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.